[上市前和上市后授权开发及临床评估的风险] - Suppr

[The stakes of pre- and post-market authorization development and clinical assessment].

Schwebig Annick

Actelion pharmaceuticals France SAS, 75001 Paris, France.

Presse Med. 2012 May;41 Suppl 1:S6-8. doi: 10.1016/j.lpm.2012.02.026. Epub 2012 Apr 6.

Abstract

摘要

Presse Med. 2012 May;41 Suppl 1:S6-8. doi: 10.1016/j.lpm.2012.02.026. Epub 2012 Apr 6.

Clin Pharmacol Ther. 2012 Aug;92(2):153-5. doi: 10.1038/clpt.2012.92.

Clin Pharmacol Ther. 2012 Aug;92(2):258-61. doi: 10.1038/clpt.2012.80. Epub 2012 Jun 27.

Presse Med. 2012 May;41 Suppl 1:S15-9. doi: 10.1016/j.lpm.2012.02.023. Epub 2012 Mar 30.

Clin Pharmacol Ther. 2012 Aug;92(2):262-4. doi: 10.1038/clpt.2012.87. Epub 2012 Jun 27.

Clin Pharmacol Ther. 2012 Dec;92(6):694; author reply 695. doi: 10.1038/clpt.2012.166. Epub 2012 Oct 17.

Drug Discov Today. 2012 Jul;17(13-14):660-4. doi: 10.1016/j.drudis.2012.02.005. Epub 2012 Feb 17.

Med Device Technol. 2002 Dec;13(10):35-8.

Nat Biotechnol. 2006 May;24(5):478. doi: 10.1038/nbt0506-478.

Drug Discov Today. 2011 Dec;16(23-24):999-1000. doi: 10.1016/j.drudis.2011.10.004. Epub 2011 Oct 14.

20分钟写一篇综述，助力文献阅读效率提升50倍。

大模型驱动的PubMed中文搜索引擎

学术文献翻译模型，支持多种主流文档格式。